What topics does this cannabis study cover?

This study covers research on: Pain, Inflammation.

Where was this research published?

Published in Journal of cannabis research on June 19, 2026.

CBD vaping eases pain but may damage your lungs

Q: What did this research study find?

This study examined the effects of vaporized *CBD* on neuropathic pain in rats with sciatic nerve injury, while simultaneously investigating potential lung damage from the vaping process. The researchers used a custom-built automated vaping system to precisely control *CBD* vapor exposure and found

Effect of vaporized Cannabidiol (CBD) on neuropathic pain and its potential implication for development of chronic lung inflammation in rats.

Journal of cannabis research • June 19, 2026 • Moderately Relevant

🤖

AI Summary

This study examined the effects of vaporized CBD on neuropathic pain in rats with sciatic nerve injury, while simultaneously investigating potential lung damage from the vaping process. The researchers used a custom-built automated vaping system to precisely control CBD vapor exposure and found that vaporized CBD significantly reduced neuropathic pain, likely through modulation of cytokines and the NLRP3 inflammasome pathway. This pain relief mechanism suggests that CBD vaping could offer benefits for patients struggling with chronic neuropathic pain that doesn't respond well to traditional medications.

However, the research revealed a critical tradeoff: while CBD itself provided pain relief, the chemical additives commonly used in e-cigarettes—specifically propylene glycol and vegetable glycerin (PG/VG)—triggered substantial inflammatory responses in lung tissue. These additives are standard components in vaping products but demonstrated significant potential for causing lung injury through inflammation. The study suggests that the NLRP3 inflammasome pathway may be central to understanding how these vaping additives harm lung tissue.

The findings highlight an important public health consideration: vaping CBD may help neuropathic pain patients, but the long-term lung effects could pose serious health risks. Users and clinicians must weigh the short-term pain management benefits against potential chronic lung inflammation and injury. This research underscores the need for safer delivery methods for CBD therapy and stricter regulation of vaping additive safety, particularly for medical cannabis users seeking therapeutic benefits.

📄 Original Abstract

Cannabidiol (CBD) use in e-cigarettes is increasing, and its vaping involves using CBD in conjunction with other chemical additives such as propylene glycol (PG), vegetable glycerin (VG) and food flavorings, which help vaporize the CBD and enhance the vaping experience. Chronic neuropathic pain is challenging to treat with current medications, and there is growing interest in the use of medical cannabis for this condition. While the effects of vaping CBD could be beneficial for people with neuropathic pain, the potential detrimental effects on the lungs after continued exposure are not fully known. Whereas acute respiratory failure has been associated with vaping Cannabis, this study was undertaken to assess effects of CBD vaping on lung pathology and analgesic effectiveness in rats with sciatic nerve chronic constriction injury and examine potential mechanisms underlying the pathophysiology associated with CBD vaping. We used an in-house designed and assembled prototype of an automated vaping exposure system that enables precise quantitation of vaping for in-vivo exposure of rats with neuropathic pain. Our results showed that CBD vapor exposure significantly alleviated pain, and modulation of cytokines and the NLRP3 (NOD-like receptor family, pyrin domain-containing 3) inflammasome pathway may underlie the CBD-induced effects in lung tissue, thereby affecting lung pathophysiology. Further, exposure to chemical additives like PGVG (Propylene Glycol and Vegetable Glycerin) resulted in a substantial inflammatory response indicating that these substances are by no means safe additives in e-cigarettes. Thus, while CBD vaping may be beneficial in the management of neuropathic pain, it may cause substantial lung injury by promoting significant inflammatory changes in the lung.

Paper Type

📄 Research

Publication

Journal: Journal of cannabis research
Published: June 19, 2026
PMID: 42321942
DOI: 10.1186/s42238-026-00459-z

Authors (6)

Priyadarshini Dutta Department of Medicine, Division of Allergy, Immunology, and Rheumatology, Jacobs School of Medicine and Biomedical Sciences, Clinical Translational Research Center, University at Buffalo, The State University of New York, Buffalo, NY, 14203, USA.
Ignacio Javier Novoa Cornejo Department of Rehabilitation Science, School of Public Health and Health Professions, University at Buffalo, The State University of New York, 633 Kimball Tower, Buffalo, NY, 14214, USA.
Vijaya Prakash Krishnan Muthaiah Department of Rehabilitation Science, School of Public Health and Health Professions, University at Buffalo, The State University of New York, 633 Kimball Tower, Buffalo, NY, 14214, USA.
Ravikumar Aalinkeel Department of Medicine, Division of Allergy, Immunology, and Rheumatology, Jacobs School of Medicine and Biomedical Sciences, Clinical Translational Research Center, University at Buffalo, The State University of New York, Buffalo, NY, 14203, USA.
Tracey A Ignatowski Department of Pathology and Anatomical Sciences, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Room 4256, 955 Main Street, Buffalo, NY, 14203, USA. tai1@buffalo.edu.
+1 more authors